Disease phenotype | Item in this table | Key references | Gene symbol (chromosome)
protein | All allelic disease phenotypes - locus/disease symbols |
| Spastic paraplegia 3, autosomal dominant (Strumpell disease) - (AD) | 15.1 | | |  | Familial spastic paraplegia, autosomal dominant, 1 -FSP1 | | Spastic paraplegia 3A -SPG3A |
|
| Spastic paraplegia 4, autosomal dominant - (AD) | 15.2 | | | | Familial spastic paraplegia, autosomal dominant, 2 -FSP2 | | Spastic paraplegia 4 -SPG4 |
|
| Spastic paraplegia 6, autosomal dominant - (AD) | 15.3 | | | non-imprinted in Prader-Willi/Angelman syndrome 1
|
|
| | Spastic paraplegia 6 uncomplicated,autosomal dominant,Strumpell-Lorrain type -SPG6 |
|
| Spastic paraplegia 8, autosomal dominant - (AD) | 15.4 | | | | Spastic paraplegia 8 -SPG8 |
|
| Spastic paraplegia 9, autosomal dominant - (AD) | 15.5 | | | | Spastic paraplegia 9 -SPG9 |
|
| Spastic paraplegia 10, autosomal dominant - (AD) | 15.6 | | | | Spastic paraplegia 10 -SPG10 |
|
| Spastic paraplegia 12, autosomal dominant - (AD) | 15.7 | | | | Spastic paraplegia 12 -SPG12 |
|
| Spastic paraplegia 13, autosomal dominant - (AD) | 15.8 | | | heat shock 60kDa protein 1 (chaperonin)
|
|
| | Spastic paraplegia 13 -SPG13 |
|
| Spastic paraplegia 17, autosomal dominant (Silver) - (AD) | 15.9 | | | | Neuronopathy, distal hereditary motor, type V -HMN5 | | Spastic paraplegia 17 -SPG17 |
|
| Spastic paraplegia 19, autosomal dominant - (AD) | 15.10 | | | | Spastic paraplegia 19 -SPG19 |
|
| Spastic paraplegia 29, autosomal dominant - (AD) | 15.11 | | | | Spastic paraplegia 29 -SPG29 |
|
| Spastic paraplegia 31, autosomal dominant - (AD) | 15.12 | | | receptor accessory protein 1
|
|
| | Spastic paraplegia 31 -SPG31 |
|
| Spastic paraplegia 33, autosomal dominant - (AD) | 15.13 | | | | Spastic paraplegia 33 -SPG33 |
|
| Spastic paraplegia 37, autosomal dominant - (AD) | 15.14 | | | | spastic paraplegia 37, autosomal dominant -SPG37 |
|
| Spastic paraplegia 38, autosomal dominant - (AD) | 15.15 | | | | spastic paraplegia 38, autosomal dominant -SPG38 |
|
| Spastic paraplegia 5, autosomal recessive - (AR) | 15.16 | | | | Spastic paraplegia 5A -SPG5A |
|
| Spastic paraplegia 7, autosomal recessive - (AR) | 15.17 | | | | Spastic paraplegia 7 -SPG7 |
|
| Spastic paraplegia 11, autosomal recessive - (AR) | 15.18 | | | | Spastic paraplegia 11 -SPG11 |
|
| Spastic paraplegia 14, autosomal recessive - (AR) | 15.19 | | | | Spastic paraplegia 14 -SPG14 |
|
| Spastic paraplegia 15, autosomal recessive (Kjellin syndrome) - (AR) | 15.20 | | | | Spastic paraplegia 15 -SPG15 |
|
| Spastic paraplegia 20 (Troyer) - (AR) | 15.21 | | | | Spastic paraplegia 20 -SPG20 |
|
| Spastic paraplegia 21 (Mast) - (AR) | 15.22 | | | | Spastic paraplegia 20 -SPG21 |
|
| Spastic paraplegia 23 (Lison) - (AR) | 15.23 | | | | Spastic paraplegia 23 -SPG23 |
|
| Spastic paraplegia 24 - (AR) | 15.24 | | | | Spastic paraplegia 24 -SPG24 |
|
| Spastic paraplegia 25 - (AR) | 15.25 | | | | Spastic paraplegia 25 -SPG25 |
|
| Spastic paraplegia 26 - (AR) | 15.26 | | | | Spastic paraplegia 26 -SPG26 |
|
| Spastic paraplegia 27 - (AR) | 15.27 | | | | Spastic paraplegia 27 -SPG27 |
|
| Spastic paraplegia 28 - (AR) | 15.28 | | | | Spastic paraplegia 20 -SPG28 |
|
| Spastic paraplegia 30 - (AR) | 15.29 | | | | Spastic paraplegia 30 -SPG30 |
|
| Spastic paraplegia 32, autosomal recessive - (AR) | 15.30 | | | | spastic paraplegia 32, autosomal recessive -SPG32 |
|
| Spastic paraplegia 35, autosomal recessive - (AR) | 15.31 | | | | spastic paraplegia 35, autosomal recessive -SPG35 |
|
| Spastic paraplegia 39, autosomal recessive - (AR) | 15.32 | | | patatin-like phospholipase domain containing 6
|
|
| | spastic paraplegia 39, autosomal recessive -SPG39 |
|
| Spastic paraplegia, complicated recessive (Sjögren-Larsson syndrome) - (AR) | 15.33 | | | aldehyde dehydrogenase 3A2
|
|
| | Aldehyde dehydrogenase, family 3, subfamily A, member 2 -ALDH3A2 | | Fatty aldehyde dehydrogenase -FALDH | | Sjogren-Larsson syndrome -SLS |
|
| Infantile-onset ascending spastic paraplegia - (AR) | 15.34 | | | | Amyotrophic lateral sclerosis, juvenile -ALS2 | | Primary lateral sclerosis, juvenile -PLSJ | | Spastic paralysis, infantile onset ascending -IAHSP |
|
| Spastic paraplegias, X-linked type 1 (MASA syndrome X-linked hydrocephalus) - (XR) | 15.35 | | | L1 cell adhesion molecule
|
|
| | CRASH syndrome -L1CAM | | CRASH syndrome -HSAS | | Hydrocephalus with Hirschspung disease and cleft palate -HSCR | | MASA syndrome -L1CAM |
|
| Spastic paraplegias, X-linked type 2 - (XR) | 15.36 | | | | Pelizaeus-Merzbacher disease -PMD | | Spastic paraplegia 2 -SPG2 |
|
| Spastic paraplegia, X-linked type 16 - (XR) | 15.37 | | | | Spastic paraplegia 16 -SPG16 |
|
| Spastic paraplegia, X-linked type 34 - (XR) | 15.38 | | | | spastic paraplegia 34, x-linked -SPG34 |
|
| Autosomal recessive spastic ataxia of Charlevoix-Saguenay - (AR) | 15.39 | | | | Autosomal recessive spastic ataxia of Charlevoix-Saguenay -ARSACS | | Spastic ataxia, Charlevoix-Saguenay type -SACS |
|
| Autosomal dominant spastic ataxia 1 - (AD) | 15.40 | | | | ataxia, spastic, 1, autosomal dominant -SPAX1 |
|
| Autosomal recessive spastic ataxia 2 - (AR) | 15.41 | | | | ataxia, spastic, 2, autosomal recessive -SPAX2 |
|
| Autosomal recessive spastic ataxia with frequent white matter changes - (AR) | 15.42 | | | | autosomal recessive spastic ataxia with leukoencephalopathy -ARSAL |
|
